FiscalNote’s PolicyNote MCP approved for OpenAI App Store

FiscalNote’s PolicyNote MCP was approved and listed in the OpenAI App Store, enabling programmatic access to its legislative/regulatory data inside ChatGPT (SOC 2 Type 2; pricing controlled by FiscalNote) and a Memorandum of Understanding with D&A Advisory to distribute in Asia. However, FiscalNote reported a Q4 2025 EPS of -$1.45 vs consensus -$0.06 (negative surprise -2316.67%) and revenue of $22.2M vs $23.01M expected; shares are down ~94% over the past year and trade near a 52‑week low of $0.70 (market cap ~$11.42M).

Analysis

Embedding structured policy data into LLM-driven workflows materially shortens the sales cycle if conversion economics hold — frictional onboarding and fast time-to-value are the two levers that turn distribution into recurring revenue. Concretely, moving from a traditional 12–18 month enterprise sales cycle to a product-led 1–3 month activation window would require only an order-of-magnitude increase in trial-to-paid conversion and a modest uplift in ARPU to shift the company from cash-burn story to viable SaaS scale within 12–24 months.

The countervailing risk is platform concentration and monetization velocity. Distribution through a third-party AI interface lowers customer acquisition cost but hands pricing leverage and platform dependency to that provider; a single adverse commercial or technical change could compress revenue growth or raise churn dramatically. With a tiny market cap and impaired earnings runway, refinancing or equity dilution is the highest-probability near-term outcome absent demonstrable ARR acceleration within the next two quarters.

A credible path to upside exists but is binary: sustained enterprise adoption across non-U.S. geographies or a strategic tuck-in by an incumbent data vendor would re-rate the equity. Absent those, downside is amplified by low liquidity and short interest mechanics — a quick negative surprise (missed bookings or lost distribution terms) could cascade into steep forced selling, while positive adoption metrics would likely take 12–18 months to reflect meaningfully in cash flow.

Key Decisions for Investors

• Short NOTE equity sized 0.5–1.0% NAV, time horizon 3–6 months. Target 50–70% downside on refinancing/dilution thesis; place hard stop at +20% to limit borrow squeeze risk. Rationale: earnings/cash runway are the dominant near-term drivers and a negative earnings cadence will likely compress market cap further.
• Pair trade: Short NOTE / Long TRI (Thomson Reuters) 1:1 notional, horizon 6–12 months. Expect incumbents to capture migration of enterprise policy spend; target relative alpha of 15–25% while keeping gross exposure low to limit firm-level beta.
• Buy long-dated OTM puts on NOTE (6–12 month expiries) sized as a tail-hedge (cost budget 0.25% NAV). This offers asymmetric payoff if platform or commercial terms change abruptly and liquidity evaporates; acceptable to take near-total premium loss given downside skew.
• Speculative long (small size <=0.25% NAV): buy a defined-risk call spread on NOTE with 9–12 month tenor to capture binary upside from major enterprise win or strategic M&A. Cap loss to premium while maintaining optionality for the 12–18 month product adoption cycle.